<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02415374</url>
  </required_header>
  <id_info>
    <org_study_id>PEP-1314</org_study_id>
    <nct_id>NCT02415374</nct_id>
  </id_info>
  <brief_title>Bioavailability and Metabolism of Avenanthramide: a Novel Oat Phytochemical</brief_title>
  <official_title>Bioavailability and Metabolism of Avenanthramide: a Novel Oat Phytochemical</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PepsiCo Global R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PepsiCo Global R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine whether orally ingested oat avenanthramides (AVA) in
      oat flour cookies are bioavailable in humans by measuring plasma and urine concentrations of
      AVAs and their potential metabolites after ingestion. The blood and urine concentrations will
      be quantified at several different time points after the oat flour cookies are consumed to
      characterize the &quot;concentration-time profile&quot;.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2015</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>iAUC for each AVA</measure>
    <time_frame>0-10 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cmax for each AVA</measure>
    <time_frame>0-10 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Tmax for each AVA</measure>
    <time_frame>0-10 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>T1/2 for each AVA</measure>
    <time_frame>0-10 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Bioavailability</condition>
  <condition>Metabolism</condition>
  <condition>Avenanthramides</condition>
  <arm_group>
    <arm_group_label>Low-AVA oat flour cookies</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Three low-AVA oat flour cookies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-AVA oat flour cookies</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Three high-AVA cookies</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Avenanthramides</intervention_name>
    <description>AVAs are a group of diphenolic acids that are found only in oats (Avena sativa). In this study, each dietary group of subjects will receive three cookies made with oat flour containing high-AVA (H-AVA, 229.56 mg/kg) and low-AVA (L-AVA, 32.69 mg/kg).</description>
    <arm_group_label>Low-AVA oat flour cookies</arm_group_label>
    <arm_group_label>High-AVA oat flour cookies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female non-obese subjects (18kg/M2&lt;BMI&lt;28kg/M2)

          -  Age 20-45 years)

          -  Sign an informed consent form approved by UMN-IRB

          -  Willing to avoid oat consumption and rigorous physical activity the day prior to and
             through test, and consume a low-flavonoid diet for 1 week prior to the study

        Exclusion Criteria:

          -  Presence of GI conditions that interfere with absorption;

          -  Clinically significant endocrine, cardiovascular, pulmonary, renal, hepatic,
             pancreatic, biliary or neurologic disorders;

          -  Major trauma or surgery within 3 months of visit;

          -  Cancer in the prior 2 years;

          -  Allergic to oat products;

          -  Women who are pregnant or lactating;

          -  Smoking;

          -  Drinking alcohol &gt;5 drinks/week;

          -  Using nutraceuticals;

          -  Blood pressure medication;

          -  NSAID (&gt;800 mg ibuprofen/week);

          -  Vitamin supplementation;

          -  Anticoagulants or hypoglycemic drugs;

          -  Oat products consumption the day before the test;

          -  Rigorous physical activity the day before the test;

          -  Consumption of a high-flavonoid diet in the week prior to the test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li Li Ji, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Kinesiology (Cooke Hall), 1906 University Ave. SE, Minneapolis, MN 55455</affiliation>
  </overall_official>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2015</study_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

